HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.

Abstract
Host defense-derived peptides have emerged as a novel strategy for the development of alternative anticancer therapies. In this study we report on characteristic features of human lactoferricin (hLFcin) derivatives which facilitate specific killing of cancer cells of melanoma, glioblastoma and rhabdomyosarcoma compared with non-specific derivatives and the synthetic peptide RW-AH. Changes in amino acid sequence of hLFcin providing 9-11 amino acids stretched derivatives LF11-316, -318 and -322 only yielded low antitumor activity. However, the addition of the repeat (di-peptide) and the retro-repeat (di-retro-peptide) sequences highly improved cancer cell toxicity up to 100% at 20 μM peptide concentration. Compared to the complete parent sequence hLFcin the derivatives showed toxicity on the melanoma cell line A375 increased by 10-fold and on the glioblastoma cell line U-87mg by 2-3-fold. Reduced killing velocity, apoptotic blebbing, activation of caspase 3/7 and formation of apoptotic DNA fragments proved that the active and cancer selective peptides, e.g. R-DIM-P-LF11-322, trigger apoptosis, whereas highly active, though non-selective peptides, such as DIM-LF11-318 and RW-AH seem to kill rapidly via necrosis inducing membrane lyses. Structural studies revealed specific toxicity on cancer cells by peptide derivatives with loop structures, whereas non-specific peptides comprised α-helical structures without loop. Model studies with the cancer membrane mimic phosphatidylserine (PS) gave strong evidence that PS only exposed by cancer cells is an important target for specific hLFcin derivatives. Other negatively charged membrane exposed molecules as sialic acid, heparan and chondroitin sulfate were shown to have minor impact on peptide activity.
AuthorsSabrina Riedl, Regina Leber, Beate Rinner, Helmut Schaider, Karl Lohner, Dagmar Zweytick
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1848 Issue 11 Pt A Pg. 2918-31 (Nov 2015) ISSN: 0006-3002 [Print] Netherlands
PMID26239537 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015. Published by Elsevier B.V.
Chemical References
  • Dipeptides
  • Lipid Bilayers
  • Membrane Lipids
  • Phosphatidylserines
  • lactoferricin B
  • Lactoferrin
Topics
  • Amino Acid Sequence
  • Apoptosis (drug effects)
  • Calorimetry, Differential Scanning
  • Cell Line, Tumor
  • Cell Membrane (chemistry, drug effects, metabolism)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Circular Dichroism
  • Dipeptides (chemistry, pharmacology)
  • Dose-Response Relationship, Drug
  • Humans
  • Lactoferrin (chemistry, pharmacology)
  • Lipid Bilayers (chemistry, metabolism)
  • Membrane Lipids (antagonists & inhibitors, chemistry, metabolism)
  • Microscopy, Fluorescence
  • Models, Molecular
  • Molecular Sequence Data
  • Phosphatidylserines (antagonists & inhibitors, chemistry, metabolism)
  • Protein Structure, Secondary
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: